The HFEA welcomes this timely and important report from the Nuffield Council on Bioethics. We share the Council’s belief that continuing public debate about these issues is important; the HFEA will lead this debate. We will launch a public consultation in September 2012, as part of a wider programme of public engagement throughout the year. Our aim is to facilitate a lively and informed debate in order to gauge public perceptions of the ethical and social issues surrounding the use of IVF techniques designed to prevent mitochondrial disease in treatment.
We will report our findings to Ministers in Spring 2013.
The report from the Nuffield will no doubt help inform our public engagement activities and contribute to our consultation which we will launch in September.
To find out more about the consultation and how to get involved see: http://www.hfea.gov.uk/6896.html
Notes to editors
The full Nuffield Council on Bioethics report on ‘Novel techniques for the prevention of mitochondrial DNA disorders’ can be downloaded here
The HFEA is the independent regulator for IVF treatment and embryo research. Our role is to protect patients and the public interest, to drive improvement in the treatment and research sectors and to provide information to the public and policymakers about treatment and research.
The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA’s principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), artificial insemination (AI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos. See www.hfea.gov.uk for further details.
For further information please contact the HFEA press office on 020 7291 8226 or email email@example.com